Evidence map›Paper›PMID 41538097›Full record

ArticleApplied biochemistry and biotechnology2026

Optimization of Expression and Thermostability of Terminal Deoxynucleotidyl Transferase Through Iterative Mutagenesis and Computational Design.

Ilya Nikiteev, Julia Kuzmina, Irina Rog, Alisa Bugrova, Ivan Gushchin, Denis Naberezhnov, Marina Shevelyova, Oksana Maksimenko, Kamil Zaynullin, Oleg Fedorov

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ilya NikiteevResearch Institute of System Biology and Medicine, Moscow, 117246, Russia. nikiteev.ilya@mail.ru.ORCID http://orcid.org/0009-0001-0657-6305
Julia KuzminaResearch Institute of System Biology and Medicine, Moscow, 117246, Russia.
Irina RogResearch Institute of System Biology and Medicine, Moscow, 117246, Russia.
Alisa BugrovaResearch Center for Molecular Mechanisms of Aging and Age-Related Diseases, Moscow Institute of Physics and Technology, Dolgoprudny, 141700, Russia.
Ivan GushchinResearch Center for Molecular Mechanisms of Aging and Age-Related Diseases, Moscow Institute of Physics and Technology, Dolgoprudny, 141700, Russia.
Denis NaberezhnovResearch Institute of System Biology and Medicine, Moscow, 117246, Russia.
Marina ShevelyovaInstitute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino, 142290, Russia.
Oksana MaksimenkoInstitute of Gene Biology, Russian Academy of Sciences, Moscow, 119334, Russia.
Kamil ZaynullinResearch Institute of System Biology and Medicine, Moscow, 117246, Russia.
Oleg FedorovResearch Institute of System Biology and Medicine, Moscow, 117246, Russia.

Funding

Ministry of Science and Higher Education agreement 075-03-2025-662, project FSMG-2025-0003Russian state task 125041005130-8
6 · The paper itself

Abstract

Terminal deoxynucleotidyl transferase (TdT) is a template-independent polymerase that catalyzes the addition of deoxynucleoside triphosphates to the 3'-terminus of a DNA strand. While TdT is a key enzyme for developing enzymatic DNA synthesis technologies, its inherent low thermal stability presents a significant limitation. This study aims to improve the thermostability of TdT from Mus musculus through a combination of site-saturation mutagenesis and rational design. Residues for saturation mutagenesis were identified using B-factor analysis and the B-FITTER program, while promising substitutions for rational design were selected using Foldit, ProteinMPNN and CARBonAra. Through several iterations of mutagenesis, we obtained two highly promising variants. The first one, dubbed A4, obtained solely through saturation mutagenesis, showed a 26-fold higher expression level than the WT protein. The second one, dubbed mutant 275, demonstrated exceptional stability, showing no significant loss of activity after 180 min of incubation at 45 °C - conditions under which the wild-type enzyme's half-life was less than 2 min. This corresponds to a > 120-fold increase in stability. Additionally, its melting temperature (Tm) was increased by 6.5 °C. Moreover, mutant 275 demonstrated a 4- to 6-fold increase in catalytic activity at 37 °C. This significant enhancement in thermostability was achieved after four rounds of iterative mutagenesis and is attributed to the formation of a stabilizing salt bridge network on the protein surface, distant from the active site. The obtained thermostable TdT variants serve as robust scaffolds for further engineering to improve activity towards the 3'-reversibly blocked nucleotides required for next-generation enzymatic DNA synthesis.

Indexed as

DNA NucleotidylexotransferaseMutagenesisMutagenesis, Site-DirectedTemperatureAnimalsEnzyme StabilityMiceProtein EngineeringDNA NucleotidylexotransferaseComputational protein designEnzymatic DNA synthesisProtein engineeringSite-saturation mutagenesisTerminal deoxynucleotidyl transferaseThermostability

Identifiers

PMID41538097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.